BRCA2 and breast carcinoma: To capture a high-risk population, such as women with germline BRCA1 and BRCA2 mutations, family breast cancer history, hormone therapy and smoking history, we assume an increase of breast cancer incidence by a factor of 5 [33] over the baseline case.